Plasma PAMG5 levels were significantly higher in the PD group compared with HC, with relatively high sensitivity and specificity, which suggests that plasma PGAM5 may be a diagnostic biomarker for PD, especially among elderly patients (age >60 years) and patients without HTN. Here, PGAM5 is linked to Parkinson disease.